These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
365 related items for PubMed ID: 10867613
1. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1. Ryuko K, Schol DJ, Snijdewint FG, von Mensdorff-Pouilly S, Poort-Keesom RJ, Karuntu-Wanamarta YA, Verstraeten RA, Miyazaki K, Kenemans P, Hilgers J. Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613 [Abstract] [Full Text] [Related]
2. Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation. Karsten U, Diotel C, Klich G, Paulsen H, Goletz S, Müller S, Hanisch FG. Cancer Res; 1998 Jun 15; 58(12):2541-9. PubMed ID: 9635576 [Abstract] [Full Text] [Related]
3. Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides. von Mensdorff-Pouilly S, Petrakou E, Kenemans P, van Uffelen K, Verstraeten AA, Snijdewint FG, van Kamp GJ, Schol DJ, Reis CA, Price MR, Livingston PO, Hilgers J. Int J Cancer; 2000 Jun 01; 86(5):702-12. PubMed ID: 10797294 [Abstract] [Full Text] [Related]
4. Characterization of a panel of monoclonal antibodies using GalNAc glycosylated peptides and recombinant MUC1. Reis CA, Hassan H, Bennett EP, Clausen H. Tumour Biol; 1998 Jun 01; 19 Suppl 1():127-33. PubMed ID: 9422098 [Abstract] [Full Text] [Related]
5. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats. Hanisch FG, Stadie T, Bosslet K. Cancer Res; 1995 Sep 15; 55(18):4036-40. PubMed ID: 7545084 [Abstract] [Full Text] [Related]
6. T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1. Pisarev VM, Kinarsky L, Caffrey T, Hanisch FG, Sanderson S, Hollingsworth MA, Sherman S. Int Immunopharmacol; 2005 Feb 15; 5(2):315-30. PubMed ID: 15652762 [Abstract] [Full Text] [Related]
7. Epitope characterization of MUC1 antibodies. Blockzjil A, Nilsson K, Nilsson O. Tumour Biol; 1998 Feb 15; 19 Suppl 1():46-56. PubMed ID: 9422088 [Abstract] [Full Text] [Related]
8. 'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequence. Schol DJ, Meulenbroek MF, Snijdewint FG, von Mensdorff-Pouilly S, Verstraeten RA, Murakami F, Kenemans P, Hilgers J. Tumour Biol; 1998 Feb 15; 19 Suppl 1():35-45. PubMed ID: 9422087 [Abstract] [Full Text] [Related]
9. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma. Henderikx P, Kandilogiannaki M, Petrarca C, von Mensdorff-Pouilly S, Hilgers JH, Krambovitis E, Arends JW, Hoogenboom HR. Cancer Res; 1998 Oct 01; 58(19):4324-32. PubMed ID: 9766660 [Abstract] [Full Text] [Related]
10. N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts. Nishimori I, Perini F, Mountjoy KP, Sanderson SD, Johnson N, Cerny RL, Gross ML, Fontenot JD, Hollingsworth MA. Cancer Res; 1994 Jul 15; 54(14):3738-44. PubMed ID: 8033093 [Abstract] [Full Text] [Related]
11. Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients. Snijdewint FG, von Mensdorff-Pouilly S, Karuntu-Wanamarta AH, Verstraeten AA, Livingston PO, Hilgers J, Kenemans P. Int J Cancer; 2001 Jul 01; 93(1):97-106. PubMed ID: 11391628 [Abstract] [Full Text] [Related]
12. Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat. Bennett EP, Hassan H, Mandel U, Mirgorodskaya E, Roepstorff P, Burchell J, Taylor-Papadimitriou J, Hollingsworth MA, Merkx G, van Kessel AG, Eiberg H, Steffensen R, Clausen H. J Biol Chem; 1998 Nov 13; 273(46):30472-81. PubMed ID: 9804815 [Abstract] [Full Text] [Related]
13. Characterization of an anti-MUC1 monoclonal antibody with potential as a cancer vaccine. Qi W, Schultes BC, Liu D, Kuzma M, Decker W, Madiyalakan R. Hybrid Hybridomics; 2001 Nov 13; 20(5-6):313-24. PubMed ID: 11839249 [Abstract] [Full Text] [Related]
14. The epitope recognized by the unique anti-MUC1 monoclonal antibody MY.1E12 involves sialyl alpha 2-3galactosyl beta 1-3N-acetylgalactosaminide linked to a distinct threonine residue in the MUC1 tandem repeat. Takeuchi H, Kato K, Denda-Nagai K, Hanisch FG, Clausen H, Irimura T. J Immunol Methods; 2002 Dec 15; 270(2):199-209. PubMed ID: 12379325 [Abstract] [Full Text] [Related]
15. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study. Grinstead JS, Schuman JT, Campbell AP. Biochemistry; 2003 Dec 09; 42(48):14293-305. PubMed ID: 14640698 [Abstract] [Full Text] [Related]
16. Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies. Spencer DI, Price MR, Tendler SJ, De Matteis CI, Stadie T, Hanisch FG. Cancer Lett; 1996 Feb 27; 100(1-2):11-5. PubMed ID: 8620429 [Abstract] [Full Text] [Related]
17. Epitope mapping of anti-breast and anti-ovarian mucin monoclonal antibodies. Xing PX, Prenzoska J, McKenzie IF. Mol Immunol; 1992 May 27; 29(5):641-50. PubMed ID: 1374842 [Abstract] [Full Text] [Related]
18. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides. Spencer DI, Missailidis S, Denton G, Murray A, Brady K, Matteis CI, Searle MS, Tendler SJ, Price MR. Biospectroscopy; 1999 May 27; 5(2):79-91. PubMed ID: 10217327 [Abstract] [Full Text] [Related]
19. Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy. Zhou D, Xu L, Huang W, Tonn T. Molecules; 2018 May 31; 23(6):. PubMed ID: 29857542 [Abstract] [Full Text] [Related]